Germline RAD51C mutations confer susceptibility to ovarian cancer
暂无分享,去创建一个
S. Seal | N. Rahman | A. Antoniou | M. Gore | D. Eccles | C. Turnbull | A. Renwick | Elise Ruark | D. Hughes | M. Warren-Perry | D. Evans | K. Snape | C. Loveday | R. Xicola | Emma Ramsay
[1] D. Easton,et al. Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk Mutations , 2012, Genetic epidemiology.
[2] Samantha E. Boyle,et al. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients , 2012, Hereditary Cancer in Clinical Practice.
[3] Susan L. Neuhausen,et al. RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families , 2011, PloS one.
[4] Deborah Hughes,et al. Germline mutations in RAD51D confer susceptibility to ovarian cancer , 2011, Nature Genetics.
[5] J. Schleutker,et al. RAD51C is a susceptibility gene for ovarian cancer. , 2011, Human molecular genetics.
[6] A. Mannermaa,et al. Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility , 2011, Breast Cancer Research and Treatment.
[7] Yuntao Xie,et al. RAD51C germline mutations in Chinese women with familial breast cancer , 2011, Breast Cancer Research and Treatment.
[8] P. Pérez-Segura,et al. A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families , 2011, Breast Cancer Research and Treatment.
[9] R. Scott,et al. BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer , 2011, Breast Cancer Research and Treatment.
[10] D. Palli,et al. Mutation screening of RAD51C in male breast cancer patients , 2011, Breast Cancer Research.
[11] Marc Tischkowitz,et al. RAD51C germline mutations in breast and ovarian cancer patients , 2010, Breast Cancer Research.
[12] Jing Zhang,et al. Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer , 2010, Breast Cancer Research and Treatment.
[13] E. Levy-Lahad,et al. Fanconi anemia and breast cancer susceptibility meet again , 2010, Nature Genetics.
[14] Dieter Niederacher,et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene , 2010, Nature Genetics.
[15] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[16] Nazneen Rahman,et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles , 2006, Nature Genetics.
[17] N. Rahman,et al. ATM and breast cancer susceptibility , 2006, Oncogene.
[18] D. Easton,et al. EMGM Abstracts , 2003, Genetic epidemiology.
[19] Christopher B. Burge,et al. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.
[20] P. Bork,et al. Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.
[21] N E Day,et al. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study , 2001, Genetic epidemiology.
[22] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[23] S. Karlin,et al. Prediction of complete gene structures in human genomic DNA. , 1997, Journal of molecular biology.
[24] David Haussler,et al. Improved splice site detection in Genie , 1997, RECOMB '97.
[25] S. Knudsen,et al. Prediction of human mRNA donor and acceptor sites from the DNA sequence. , 1991, Journal of molecular biology.
[26] Cancer incidence in five continents. Volume VIII. , 2002, IARC scientific publications.
[27] K. Lange,et al. Programs for pedigree analysis: Mendel, Fisher, and dGene , 1988, Genetic epidemiology.